Takeda Pharmaceutical Company Limited announced that at its ordinary general meeting of shareholders held on June 29, 2022 shareholders elected John Maraganore as director. Yoshiaki Fujimori and Kimberly A. Reed were newly elected to Audit and Supervisory Committee Members assumed their respective offices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,069 JPY | -0.49% | -1.86% | +0.37% |
10:21am | Takeda Pharmaceutical Receives FDA Approval for Single-Dose Injection Crohn's Disease Treatment | MT |
Apr. 18 | Takeda Says FDA Has Approved Subcutaneous Entyvio for Crohn's Disease | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.37% | 41.5B | |
+27.97% | 672B | |
+23.56% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+1.83% | 211B | |
-0.66% | 203B | |
-10.39% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces Board Appointments